FRE ASX Chart
Snapshot
Firebrick Pharma Limited (FRE) is a pharmaceutical developer focused on developing and commercializing novel formulations and uses of povidone-iodine. After more than 10 years of R&D including multiple human clinical trials, Firebrick's first product, Nasodine Nasal spray is expected to become available for sale in some countries in 2024.
Share Price Activity (ASX)
Last (Price) | |
Change | 0.00 (0.00) |
Bid / Ask | - |
Volume | |
Volume (4w avg) | |
Turnover | |
Open | |
Day Range | - |
VWAP | |
Prev Close | |
Last Trade |
Performance
1 Week | |
1 Month | |
2024 YTD | |
1 Year | |
vs Sector (1yr) | - |
vs ASX 200 (1yr) | -72.09% |
Latest Firebrick Pharma Ltd News
Announcements
Corporate Overview
Corporate Details
Head Office | Creswick VIC 3363 |
Website | www.firebrickpharma.com |
Registry | Automic Group |
Auditor | BDO Audit (WA) Pty Ltd |
Date Listed | 28 Jan 2022 |
Upcoming Calendar (Forecasted)
Date | Event |
---|---|
27/08/2024 | Report (Prelim) |
27/08/2024 | Report (Annual) |
26/02/2025 | Report (Interim) |
Former Company Names
- Firebrick Pharma Ltd has no former company names.
Sponsored Financial Content
Dividend History
DPS and Yield calculations use the Pay Date.
See Upcoming Dividends for all ASX companies.
Directors & Management
Directors
Management
Director Transactions
FRE directors must report any change in shareholding to the ASX within 5 business days.
See Director Transactions for all ASX companies.
Director Interests
The current holdings of FRE directors.
Shareholder Info
Substantial Shareholders
A substantial shareholder is a person or entity that owns 5% or more of the voting shares in a company. Shares can be held through multiple entities, so the Substantial Shareholders list differs from the Top 20 Shareholders list.
Shareholding changes less than 1% do not require notification to the market. When all “Last Notice” dates are identical, it suggests that no (or minimal) change has occurred since the most recent Annual Report.
Note: If a substantial shareholder's stake drops below 5%, the "Shareholders Selling" field shows full ownership as sold and sets "New %" to zero, even if they continue to hold shares under the limit.
Name | Last Notice | Total Shares | Shares Held (%) |
---|---|---|---|
Firebrick Pharma Limited | 10/08/2023 | 62,732,537 | 37.15 |
Biotech Design Pty Ltd | 10/08/2023 | 30,326,472 | 17.96 |
Aquarico Pty Ltd | 10/08/2023 | 30,326,472 | 17.96 |
GZ Family Holdings Pty Ltd | 27/03/2024 | 9,045,766 | 5.06 |
Shareholders Buying
12 month transaction history compiled from ASX announcements.
Date | Name | Bought | Previous % | New % |
---|---|---|---|---|
27-03-24 | GZ Family Holdings Pty Ltd | 9,045,766 | -- | 5.06 |
Shareholders Selling
12 month transaction history compiled from ASX announcements.
No sell transactions reported by Substantial Shareholders in the past 12 months.
Historical Data
Share Price History
Date | Close | Change | %Chg | Open | High | Low | Volume | Turnover |
---|---|---|---|---|---|---|---|---|
Historical Data
Year | Closing Price | Last Trade |
---|---|---|
2023 | $0.155 | 30 June |
2022 | $0.265 | 30 June |
Important note:
All year-end and CSV data is "as traded on the day" and ignores corporate actions (e.g. share splits)
All data on this page is supplied by the ASX, Morningstar and Market Index. Read the disclaimer.